TRIM22 governs tumorigenesis and protects against endometrial cancer-associated cachexia by inhibiting inflammatory response and adipose thermogenic activity

Table 2 Distribution of the AEH participants and tissue characteristics (pathological diagnosis)

	Progesterone effective group (n = 29)					Progesterone ineffective group(n = 21)
Patient number	Age (years)	Pathological diagnosis (pre-treatment)	Course of treatment (months)	Pathological diagnosis (post-treatment)	Patient number	Age (years)	Pathological diagnosis (pre-treatment)	Course of treatment (months)	Pathological diagnosis (post-treatment)
1	25	AEH	3	DC	1	32	AEH	3	NC
2	40	AEH	3	DC	2	32	AEH	3	NC
3	24	AEH	3	PE	3	37	AEH	3	NC
4	29	AEH	3	SE	4	34	AEH	3	NC
5	38	AEH	3	SE	5	32	AEH	3	NC
6	32	AEH	3	PE	6	30	AEH	3	NC
7	43	AEH	3	DC	7	29	AEH	3	LP
8	36	AEH	3	DC	8	34	AEH	3	NC
9	41	AEH	3	DC	9	39	AEH	3	LP
10	32	AEH	3	DC	10	28	AEH	3	NC
11	40	AEH	3	SE	11	31	AEH	3	NC
12	37	AEH	3	PE	12	38	AEH	3	NC
13	27	AEH	3	DC	13	32	AEH	3	NC
14	28	AEH	3	DC	14	42	AEH	3	NC
15	28	AEH	3	DC	15	32	AEH	3	NC
16	31	AEH	3	SE	16	38	AEH	3	NC
17	26	AEH	3	PE	17	34	AEH	3	NC
18	26	AEH	3	SE	18	34	AEH	3	NC
19	26	AEH	3	SE	19	41	AEH	3	NC
20	35	AEH	3	SE	20	30	AEH	3	NC
21	31	AEH	3	SE	21	41	AEH	3	NC
22	32	AEH	3	DC
23	29	AEH	3	DC
24	44	AEH	3	DC
25	29	AEH	3	SE
26	31	AEH	3	SE
27	40	AEH	3	SE
28	27	AEH	3	DC
29	40	AEH	3	PE
Progesterone effective group				&	Progesterone ineffective group				P = 0.2898
age(years) 32.655					age(years) 34.286
(Mean)					(Mean)

AEH = Atypical Endometrial Hyperplasia; DC = Decidua changed; PE = proliferative endometrium; SE = secretory endometrium; LP = lesion progressed; NC = lesion not changed

ISSN: 2049-3002